| 1 | IGF2BP3, MICB, ULBP2
|
| The RNA binding protein IMP3 facilitates tumor immune escape by downregulating the stress-induced ligands ULPB2 and MICB.
|
| Schmiedel D, Tai J, Yamin R, Berhani O, Bauman Y, Mandelboim O.
|
| Elife 5. pii: e13426. doi: 10.7554/eLife.13426. 2016
|
| 2 | ULBP2
|
| Regulation of NKG2D-ligand cell surface expression by intracellular calcium after HDAC-inhibitor treatment.
|
| Jensen H, Hagemann-Jensen M, Lauridsen F, Skov S.
|
| Mol Immunol 53(3):255-64. doi: 10.1016/j.molimm.2012.08.011. Epub 2012 Sep 8.
2013
|
| 3 | ULBP1, ULBP2, ULBP3
|
| Ras activation induces expression of Raet1 family NK receptor ligands.
|
| Liu XV, Ho SS, Tan JJ, Kamran N, Gasser S.
|
| J Immunol 189(4):1826-34. doi: 10.4049/jimmunol.1200965. Epub 2012 Jul 13.
2012
|
| 4 | ULBP1, ULBP2, ULBP3
|
| Human NK cells are alerted to induction of p53 in cancer cells by upregulation of the NKG2D ligands ULBP1 and ULBP2.
|
| Textor S, Fiegler N, Arnold A, Porgador A, Hofmann TG, Cerwenka A.
|
| Cancer Res 71(18):5998-6009. Epub 2011 Jul 15.
2011
|
| 5 | KLRK1, MICA, MICB, ULBP2
|
| The prognostic significance of soluble NKG2D ligands in B-cell chronic lymphocytic leukemia.
|
| Nückel H, Switala M, Sellmann L, Horn PA, Dürig J, Dührsen U, Küppers R, Grosse-Wilde H, Rebmann V.
|
| Leukemia 24(6):1152-9. Epub 2010 Apr 29.
2010
|
| 6 | RAET1E, RAET1G, ULBP1, ULBP2, ULBP3
|
| Single nucleotide polymorphism analysis of the NKG2D ligand cluster on the long arm of chromosome 6: Extensive polymorphisms and evidence of diversity between human populations.
|
| Antoun A, Jobson S, Cook M, O'Callaghan CA, Moss P, Briggs DC.
|
| Hum Immunol 71(6):610-20. Epub 2010 Mar 15.
2010
|
| 7 | RAET1E, RAET1F, RAET1G, ULBP1, ULBP2, ULBP3
|
| Post-translational modification of the NKG2D ligand RAET1G leads to cell surface expression of a glycosylphosphatidylinositol-linked isoform.
|
| Ohashi M, Eagle RA, Trowsdale J.
|
| J Biol Chem 285(22):16408-15. Epub 2010 Mar 19.
2010
|
| 8 | MICA, MICB, ULBP2
|
| Clinical significance of the NKG2D ligands, MICA/B and ULBP2 in ovarian cancer: high expression of ULBP2 is an indicator of poor prognosis.
|
| Li K, Mandai M, Hamanishi J, Matsumura N, Suzuki A, Yagi H, Yamaguchi K, Baba T, Fujii S, Konishi I.
|
| Cancer Immunol Immunother 58(5):641-52. Epub 2008 Sep 13. 2009
|
| 9 | ULBP1, ULBP2, ULBP3
|
| Proteasome regulation of ULBP1 transcription.
|
| Butler JE, Moore MB, Presnell SR, Chan HW, Chalupny NJ, Lutz CT.
|
| J Immunol 182(10):6600-9.
2009
|
| 10 | ULBP1, ULBP2, ULBP3
|
| Posttranslational regulation of the NKG2D ligand Mult1 in response to cell stress.
|
| Nice TJ, Coscoy L, Raulet DH.
|
| J Exp Med 206(2):287-98. Epub 2009 Jan 26.
2009
|
| 11 | ULBP1, ULBP2, ULBP3
|
| ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor.
|
| Cosman D, Mullberg J, Sutherland CL, Chin W, Armitage R, Fanslow W, Kubin M, Chalupny NJ.
|
| Immunity 14(2):123-33. 2001
|